Mesa Laboratories, Inc.
MLAB
$71.62
-$2.32-3.14%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 60.74M | 59.54M | 62.14M | 62.84M | 57.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.74M | 59.54M | 62.14M | 62.84M | 57.83M |
| Cost of Revenue | 23.41M | 22.60M | 23.72M | 23.09M | 21.92M |
| Gross Profit | 37.33M | 36.94M | 38.41M | 39.75M | 35.91M |
| SG&A Expenses | 27.56M | 28.89M | 31.85M | 28.92M | 27.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.01M | 56.48M | 60.67M | 57.06M | 53.87M |
| Operating Income | 4.72M | 3.06M | 1.47M | 5.78M | 3.96M |
| Income Before Tax | 2.00M | 7.01M | 461.00K | -2.22M | 3.81M |
| Income Tax Expenses | -477.00K | 2.27M | 7.58M | -541.00K | 384.00K |
| Earnings from Continuing Operations | 2.48M | 4.74M | -7.11M | -1.68M | 3.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.48M | 4.74M | -7.11M | -1.68M | 3.43M |
| EBIT | 4.72M | 3.06M | 1.47M | 5.78M | 3.96M |
| EBITDA | 10.57M | 9.02M | 8.97M | 11.28M | 10.03M |
| EPS Basic | 0.45 | 0.87 | -1.31 | -0.31 | 0.63 |
| Normalized Basic EPS | 0.23 | 0.80 | 0.05 | -0.26 | 0.49 |
| EPS Diluted | 0.45 | 0.85 | -1.31 | -0.31 | 0.63 |
| Normalized Diluted EPS | 0.23 | 0.79 | 0.05 | -0.26 | 0.49 |
| Average Basic Shares Outstanding | 5.51M | 5.47M | 5.44M | 5.43M | 5.41M |
| Average Diluted Shares Outstanding | 5.54M | 5.55M | 5.44M | 5.43M | 5.47M |
| Dividend Per Share | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Payout Ratio | 35.62% | 18.41% | -12.23% | -51.85% | 25.26% |